Search Tag: MRSA

ICU Management

2024 05 Jan

A ground-breaking class of antibiotics targeting drug-resistant Staphylococcus aureus (MRSA) bacteria has been discovered by applying transparent deep-learning models in medicine. Artificial intelligence (AI) is revolutionising the field, aiding scientists in unveiling the first novel antibiotics in six decades.   Designated a priority-one critical...Read more

ICU Management

2019 12 Sep

ICUs in the UK have seen an 80% drop in bloodstream infections according to NIHR Guy's and St Thomas' Biomedical Research Centre-funded research. In collaboration with Guy's and St Thomas' clinicians and researchers from ICNARC (Intensive Care National Audit & Research Centre), the study analysed 1 million adult patients from 276 NHS ICUs across the...Read more

ICU Management

2018 20 Jun

Researchers in the UK say a new test can help identify patients in intensive care units (ICUs) at great risk of developing life-threatening secondary infections, including from antibiotic-resistant bacteria such as MRSA and C. difficile . The test is used to identify the presence of markers on three immune cells that correlate with an increased...Read more

ICU Management

2016 08 Feb

Chlorhexidine baths in the ICU do not cause high levels of resistance in bacteria on patients’ skin, according to a study published in Infection Control & Hospital Epidemiology . The retrospective cohort study of patients admitted to the Barnes-Jewish Hospital ICU in St. Louis, Missouri from 2005 through 2012 included more than 500 randomly selected...Read more

ICU Management

2015 15 Sep

Virginia Tech researchers say a new group of antibiotics shows potential in fighting the bacteria Staphylococcus aureus (staph) and the antibiotic-resistant strains commonly known as MRSA. The discovery, published in Medicinal Chemistry Communications , shows that the new antibiotics are unlike contemporary antibiotics because they contain iridium,...Read more

ICU Management

2015 10 Jul

Researchers at McMaster University have developed a new diagnostic test designed to help clinicians detect infectious diseases such as hepatitis C and deadly superbugs (eg, MRSA and C. difficile) more easily and quickly. They say the new method does not require complicated equipment so tests can be run at room temperature under ordinary conditions....Read more

ICU Management

2015 13 Feb

Infections due to multidrug resistant gram negative bacilli (RGNB) in critically ill patients have been reported to be associated with increased morbidity and healthcare costs. A recent study conducted by researchers in Singapore has highlighted the heavy economic burden of RGNB infections to both the patient and hospital. "Nosocomial acquired RGNB...Read more

ICU Management

2015 19 Jan

According to a retrospective study, an antibiotic protocol that determined antibiotic use based on risk for health care-associated infections significantly increased appropriate prescription of antibiotics in a paediatric ICU. The study has been published online in Annals of the American Thoracic Society .   Researchers evaluated patients with an...Read more

ICU Management

2015 05 Jan

In the fight against drug-resistant bacteria, new drugs are urgently needed, but so are ways to maximise the effective lifespan of these drugs. Researchers at Duke University in the U.S. have developed open-source software that can predict a constantly-evolving infectious bacterium's counter-moves to a new drug before the drug is tested on patients....Read more

ICU Management

2014 11 Oct

A new study published in JAMA has determined that vancomycin, an antibiotic that came out more than 50 years ago, remains effective in treating Staphylococcus aureus bloodstream infections. The study's authors said doctors should continue to use the drug even as newer antibiotics can now be bought in the market. Staphylococcus aureus is amongst...Read more

ICU Management

2013 06 Oct

Methicillin-resistant Staphylococcus aureus (MRSA) is shown in the background (in gray). This figure depicts domains and key ligands of the penicillin binding protein 2a — a key resistance enzyme. The red molecule on the right is ceftaroline, a drug recently approved by the FDA. (Credit: University of Notre Dame) University of Notre Dame researchers...Read more

ICU Management

2013 18 Sep

A drug approved just two years ago for treating bacterial infections may hold promise for treating the potentially fatal MRSA pneumonia, according to a Henry Ford Hospital study. Researchers found that patients treated with the antibiotic ceftaroline fosamil, or CPT-F, had a lower mortality rate after 28 days than the mortality rate seen in patients...Read more

ICU Management

2013 18 Sep

Study of funding awarded to antimicrobial resistance research projects in the UK calls for political leadership and sustained and targeted spending. Although emergence of antimicrobial resistance severely threatens our future ability to treat many infections, the UK infection-research spend targeting this important area is still unacceptably...Read more

ICU Management

2013 26 Jun

Germ-fighting robots that pulse UV light are used by Loyola University Health System to fight infectious disease. Hospitals are synonymous with cleanliness and now Loyola University Health System is the first academic medical center in Illinois to take disinfection to futuristic levels. Nicknamed “Ralph” by the housekeeping staff at Gottlieb...Read more

ICU Management

2013 14 Jun

Staph infections in hospitals are a serious concern, so much so that the term Methicillin-resistant Staphylococcus aureus (MRSA) is as commonly known as MRI. Far less known is that in many of these cases, patients are infecting themselves. In heart surgeries and knee and joint-replacement procedures, up to 85 percent of staph infections after...Read more

ICU Management

2013 07 Jun

Xenex Healthcare Services announced on June 6, 2013, that Dr. Mark Stibich presented the poster “Reductions in Environmental Contamination and Hospital Infection Rates After Implementing a Pulsed-Xenon Ultraviolet (PX-UV) Disinfection System” at the International Forum on Quality & Safety in Healthcare in London. According to the poster, use of the...Read more

ICU Management

2013 06 Jun

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance. Shelley Haydel, a researcher at Arizona State University's Biodesign Institute has a new approach to developing...Read more

ICU Management

2013 16 May

Scientists at Imperial College London have identified four new proteins that act as receptors for an essential signalling molecule in bacteria such as MRSA. The receptors are thought to play an important role in enabling bacteria to respond to their environment. Their discovery provides scientists with vital clues in the hunt for new antibiotics,...Read more

ICU Management

2013 11 Apr

Xenex, a robot that emits high-intensity ultraviolet light, kills germs in an operating room at Lancaster General Hospital (Image Credit: Dan Marschka, Lancaster Online) Pulsing lights blink inside a glass-walled room in the intensive care unit at Lancaster General Hospital (LGH). Meet LGH's newest housekeeper, and its newest weapon in the fight...Read more